Cyklokapron is an antihemorrhagic medication used to reduce bleeding in certain conditions. Its active ingredient tranexamic acid works by blocking the breakdown of blood clots. This inhibition supports the formation and stability of clots in tissues where excessive fibrinolysis may occur. The drug therefore helps maintain platelet aggregation and preserves clot integrity during surgical procedures or trauma. Physiologically it modulates the fibrinolytic pathway to limit the activity of plasmin and reduce clot dissolution. The therapeutic effect is achieved through competitive binding to lysine binding sites on plasminogen preventing its activation.

Cyklokapron is the commercial name for the antifibrinolytic agent tranexamic acid. It is classified as a systemic medication that reduces excessive bleeding by interfering with clot breakdown. Its pharmacological activity stems from structural similarity to lysine which allows it to occupy binding sites on plasminogen molecules. By occupying these sites the drug prevents plasminogen from being activated into plasmin, the enzyme that degrades fibrin. This inhibition stabilizes newly formed clots and shortens the duration of bleeding episodes. Clinically it is employed in settings such as trauma surgery and certain cardiac procedures to limit blood loss. The interaction with the fibrinolytic pathway enhances hemostasis without directly affecting platelet function or coagulation cascade factors. The overall effect is a measurable decrease in transfusion requirements and surgical re-exploration rates.

Cyklokapron may cause nausea drowsiness or headache in some patients. It can also lead to low blood pressure vision changes or bleeding tendencies. Some individuals experience allergic skin reactions such as rash or itching. The medication may occasionally result in dizziness or confusion. Rarely it can affect kidney function leading to reduced urine output. Most side effects are mild and resolve without medical intervention.

Hypertension may occur as a side effect of Cyklokapron. Headache is commonly reported by users of the medication. Dizziness can be experienced alongside blood pressure changes. Nausea and vomiting sometimes accompany treatment. Thrombotic events have been documented in rare cases. Local injection site reactions such as redness may appear. Visual disturbances like blurred vision have been noted. Fatigue is another possible symptom.